Genitourinary tumours
Invited discussant abstracts 238O and 239O
Date
19 Dec 2015Session
Genitourinary tumoursPresenters
Winald GerritsenAuthors
W.R. GerritsenAuthor affiliations
- Department Of Medical Oncology, Radboud University Medical Centre Nijmegen, 6500 HB - Nijmegen/NL
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
View the abstracts discussed:
Resources from the same session
1198 - A randomized phase III study comparing neoadjuvant chemotherapy followed by concurrent chemo-radiotherapy with concurrent chemo-radiotherapy in Asian-Indian (South Asian) population with muscle invasive bladder cancer
Presenter: Shankar Jakhar
Session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
448 - Adjuvant chemotherapy in patients with muscle invasive bladder cancer after radical cystectomy: now or never?
Presenter: Mai Ezz El Din
Session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
356 - Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma
Presenter: Mian Xie
Session: Genitourinary tumours
Resources:
Abstract
972 - RECORD-4: Multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis
Presenter: Lin Yang
Session: Genitourinary tumours
Resources:
Abstract
897 - The prognostic significance of neutrophil to lymphocyte ratio and platelet count in patients with metastatic urothelial carcinoma
Presenter: Yu Li Su
Session: Genitourinary tumours
Resources:
Abstract
1292 - Treatment of locally recurrent prostate cancer following external beam radiotherapy or brachytherapy: In situ gene therapy with iodine-131 and the sodium iodide symporter gene
Presenter: Brian Davis
Session: Genitourinary tumours
Resources:
Abstract
492 - Subgroup analysis of Asian men in the PREVAIL trial of enzalutamide (ENZA) in men with chemotherapy-naïve, metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Edmund Chiong
Session: Genitourinary tumours
Resources:
Abstract
803 - Phase 3 study of radium-223 dichloride (Ra-223) in Asian patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets)
Presenter: Yinghao Sun
Session: Genitourinary tumours
Resources:
Abstract
Invited discussant abstracts 236O and 237O
Presenter: Joaquim Bellmunt
Session: Genitourinary tumours
Resources:
Slides
Webcast
Invited discussant abstracts 240PD, 241PD, 242PD and 243PD
Presenter: Oliver Sartor
Session: Genitourinary tumours
Resources:
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.